McMillan Office’s Corteva CTVA Stock Holding History

McMillan Office’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.58M	Sell	42,256 -40	-0.1%	-$3.21K	0.41%	37
2026 Q1	$3.54M	Hold	42,296	–	–	0.45%	39
2025 Q4	$2.84M	Buy	+42,296	New	+$2.73M	0.34%	46

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

McMillan Office's CTVA Position: Q2 2026 in Review

McMillan Office reduced its Corteva (CTVA) stake by 0.09% in Q2 2026, selling an estimated $3.21K and leaving 42,256 shares worth $3.58M. The position accounts for 0.41% of the portfolio, ranked #37.

McMillan Office first reported a position in CTVA in Q4 2025 and has held it in 3 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

McMillan Office held 42,256 shares of Corteva worth $3.58M as of Q2 2026.
McMillan Office sold 40 Corteva shares in Q2 2026, an estimated $3.21K.
Corteva made up 0.41% of McMillan Office's portfolio in Q2 2026, its #37 holding.
McMillan Office first reported a position in Corteva in Q4 2025 and has held it in 3 quarters since.
1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.